These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6933760)

  • 1. [Nosology of myeloproliferative disorders].
    Stobbe H
    Z Gesamte Inn Med; 1980 May; 35(9):357-60. PubMed ID: 6933760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
    Gilbert HS
    Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloproliferative diseases in childhood.
    Nix WL; Fernbach DJ
    Am J Pediatr Hematol Oncol; 1981; 3(4):397-407. PubMed ID: 6174053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
    Porse BT; Bryder D; Theilgaard-Mönch K; Hasemann MS; Anderson K; Damgaard I; Jacobsen SE; Nerlov C
    J Exp Med; 2005 Jul; 202(1):85-96. PubMed ID: 15983063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
    Kreipe HH
    Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
    Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
    Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytological and cytochemical studies in acute transformation (blastic crisis) in chronic myelogenous leukaemia.
    Ruvidic R; Jelic S
    Haematol Lat; 1969; 12(2):107-29. PubMed ID: 5265892
    [No Abstract]   [Full Text] [Related]  

  • 12. Myeloproliferative syndromes: a unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone.
    Longo DL; Whang-Peng J; Jaffe E; Triche TJ; Young RC
    Blood; 1978 Oct; 52(4):793-801. PubMed ID: 278632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic observations in chronic myeloid leukemia (CML) correlations of the cytogenetic findings with morphological cytochemical features of blast cells in various types of blastic phase.
    Oláh E; Kiss A; Jakó J; Balogh E; Rák K
    Neoplasma; 1981; 28(3):325-32. PubMed ID: 6945486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of STATs in myeloid differentiation and leukemia.
    Coffer PJ; Koenderman L; de Groot RP
    Oncogene; 2000 May; 19(21):2511-22. PubMed ID: 10851050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is leukemic transformation of donor cells possible?].
    Vinogradova OA; Savchenko VG; Domracheva EV; Parovichnikova EN; Diachenko LV; Alimova GA; Mendeleeva LP; Liubimova LS; Sokolov AN; Zhelnova EI; Pokrovskaia OS
    Ter Arkh; 2004; 76(7):28-34. PubMed ID: 15379124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of bone marrow cytology in the diagnosis of leukosis in dogs].
    Moritz A; Grünbaum EG
    Tierarztl Prax; 1993 Jun; 21(3):243-51. PubMed ID: 8346528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
    Hinterberger W
    Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
    Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
    J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
    Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
    J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice expressing the p75 CCAAT-displacement protein/Cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia.
    Cadieux C; Fournier S; Peterson AC; Bédard C; Bedell BJ; Nepveu A
    Cancer Res; 2006 Oct; 66(19):9492-501. PubMed ID: 17018605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.